ANI Pharmaceuticals, Inc. (NasdaqGM: ANIP)
Health Care · Pharmaceuticals · US
$73.79
-0.14% today · -18.6% 1Y
ANI Pharmaceuticals, Inc. (NasdaqGM: ANIP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.58B and employs 970 people.
Over the last twelve months the share price has lost 18.6%, trading between 69.58 and 97.00.
Tweenvest scores ANI Pharmaceuticals, Inc. across four factors: quality 67/100, value 77/100, growth 100/100. Its strongest factor is growth.
ANIP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.58B
- Revenue (TTM)
- $978.38M
- P/E
- 16.28
- EPS
- 4.54
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- $97.00
- 52-week low
- $69.58
- Avg volume (3M)
- —
- Shares outstanding
- 21.43M
- Employees
- 970
- Next earnings
- —
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
- ISIN
- US00182C1036
- Founded
- 2001
- Listed since
- May 5, 2000
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alembic Pharmaceuticals LimitedNSEI: APLLTD | $1.63B | Rs800.95 | -1.75% |
| Shenzhen Chipscreen Biosciences Co., Ltd.SHSE: 688321 | $1.61B | CN¥24.31 | -3.61% |
| Inner Mongolia Furui Medical Science Co., Ltd.SZSE: 300049 | $1.60B | CN¥40.49 | -14.05% |
| Consun Pharmaceutical Group LimitedSEHK: 1681 | $1.59B | HK$14.85 | +0.81% |
| CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.SZSE: 000908 | $1.58B | CN¥6.02 | +0.50% |
| Sopharma ADBUL: SFA | $1.58B | €2.62 | -0.38% |
| Eton Pharmaceuticals, Inc.NasdaqGM: ETON | $1.58B | $55.76 | +1.00% |
| Mezzion Pharma Co.,Ltd.KOSDAQ: A140410 | $1.57B | ₩69,000.00 | +1.47% |
Figures last refreshed Oct 11, 2026.